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Bilateral  ductal  carcinoma  in  situ  of  breast  is a very  rare disease  in  men.  Ductal  carcinoma  in  situ  (DCIS)  is
an  abnormal  proliferation  that involves  the ductal  epithelium  and  it has  the  potential  of  evolving  into  an
invasive  tumour.  Gynaecomastia  (female  like  breast  in  men)  is  a  benign  condition  though  it  is  associated
with  a  reported  3% incidence  of unilateral  invasive  breast  cancer.2 Synchronous  bilateral  breast  cancer
in  association  with  gynaecomastia  is exceptionally  rare.  The  recommended  treatment  for DCIS  in male
is  mastectomy.  So  far  only  2  cases  of  bilateral  DCIS  in male  patients  has  been  reported  in the  literature
treated  with  skin  and  nipple  sparing  mastectomies.  We  report  another  case  of synchronous  bilateral  DCIS
in  a  male  treated  with  skin  and  nipple  sparing  mastectomies.  A 44  year-old  man  with  history  of  long-
standing  gynecomastia.  He  had  no  identiﬁable  risk  factor  for  the  development  of  cancer.  His pre  operativeipple sparing mastectomy
kin  sparing mastectomy
assessment  of breast  including  mammograms  was  normal.  He  underwent  bilateral  subcutaneous  mas-
tectomies,  with  subsequent  incidental  diagnosis  of synchronous  bilateral  ductal  carcinoma  in situ.  The
case  was  discussed  in  multidisciplinary  team  meeting  and  the  need  for  further  surgery  was  felt  including
excision  of  nipple  areola  complex.  However  considering  patient  wishes,  cosmetic  outcome  and  recent
literature  it  was  decided  to  preserve  nipple  areola  complex  (NAC)  with  regular  follow  up evaluation.  Our
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. Introduction
Gynaecomastia is a common condition, with a reported inci-
ence of 30–50% and often bilateral.1 Histologically the normal
ale breast consists predominantly of fat with a few secondary
ucts, in gynaecomastia there is increased duct formation with
rominent stroma typically benign (Fig. 1). Ductal carcinoma in situ
DCIS) is an abnormal proliferation that involves the ductal epithe-
ium and it has the potential of evolving into an invasive tumour.
ynaecomastia is associated with a reported 3% incidence of uni-
ateral invasive breast cancer.2 Synchronous bilateral breast cancer
n association with gynaecomastia is exceptionally rare.
Herein  we present a case of synchronous incidental bilateral
CIS in man  treated with bilateral nipple sparing mastectomies. In
 large series of nipple sparing mastectomies only small percentage
f patients were found to have occult positive retro-areolar biopsies
nd it was suggested that it is safe to preserve the nipple areola
omplex if the retro-areolar biopsy is negative.3 There are at least prior reports of nipple preservation in the treatment of bilateral
CIS in men.4,5
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2. Case presentation
A  54 year-old male presented with a 4-year history of painful
enlargement of both breast. He was otherwise ﬁt and healthy
with no history of hormonal use or medications. His family his-
tory was negative for breast cancer or any other cancer. Physical
examination revealed bilateral gynaecomastia, more prominent
on right side with no suspicious nodules. Bilateral mammogram
was reported as male pattern breast with bilateral gynaecomastia
(Fig. 2).
He  ﬁrst underwent liposuction of bilateral gynaecomastia and
184 ml  of liqueﬁed breast tissue was aspirated. After an interval of
3 months, he had bilateral subcutaneous mastectomies for resid-
ual gynaecomastia and 156 g of ﬁbro-glandular tissue was excised
from right breast and 78 g from left breast. Histological examination
revealed atypical ductal hyperplasia and low-grade ductal carci-
noma in situ with papillary and cribriform pattern in both breast.
No invasive cancer was  seen. It was difﬁcult to certain about the
size of the DCIS as blocks were taken randomly from the unorien-
tated specimen, however the estimated size was  between 30 and
40 mm in maximum dimension (Fig. 3).
The  case was discussed in breast multidisciplinary team meet-
ing, and as histology was  unable to give information about the
Open access under CC BY-NC-ND license.completion of excision, the need for removing the nipple areola
complex was felt. This was  discussed with patient, however con-
sidering his wishes it was decided to preserve nipples. At 18 months
of follow-up he had no signs of recurrence of cancer (Fig. 4).
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Fig. 1. Gynecomastia.
Fig. 2. Bilateral mammograms normal.
Fig. 3. DCIS with gynecomastia.Fig. 4. Bilateral subcutaneous nipple sparing mastectomy.
3. Discussion
DCIS of the male breast is extremely rare tumour. Of all the cases
of breast cancer <1% occur in men  and DCIS accounts for approx-
imately 5% of the cases of all male breast cancers. Even more rare
is the incidental diagnosis of synchronous bilateral DCIS in asso-
ciation with surgery for benign gynaecomastia. Due to the small
number of cases in men, the management of the DCIS is based on
evidence derived from the data of female patients and from retro-
spective studies of a limited number of male patients with breast
cancer.
DCIS in males, like in females has a good prognosis and simple
mastectomy without axillary surgery or adjuvant chemo radiation
is the recommended treatment.6,7 Lumpectomy or local excision
are not considered to be preferred treatment as these lesions are
mainly subareolar and nipple excision is required. Axillary surgery
or sentinel node biopsy is unnecessary, except if the lesion is come-
docarcinoma or large where the risk of occult micro invasion would
be increased.
Preservation of nipple areola complex in breast cancer surgery
is driven mostly by patient wishes. Current literature is suggesting
low recurrence rates following nipple sparing mastectomy (NSM)
and now it is widely accepted as a prophylactic procedure but ther-
apeutic NSM is still debatable. Reported rates of nipple involvement
ranges from 0% to 58%, depending on the size of the primary tumour,
multi-centricity, and lymph node positivity.3,8,9 A review of the
literature suggests breast cancers may  be amenable to retaining
the nipple if they meet speciﬁc oncologic criteria. Data from multi-
ple series of NSM in women show that properly screened patients
have a low of local recurrence. Scchini et al.8 reported only 2 local
recurrences in a series of 123 patients who had NSM with breast
reconstruction, one had DCIS and the other cancer was invasive.
We routinely perform retro-areolar biopsy for nipple sparing mas-
tectomy in women with breast cancer. This patient had a nipple
sparing mastectomy for presumed benign breast disease, so a retro-
areolar biopsy was not performed. We  suggest routine retro-areolar
biopsies should be performed if there is an intention to do nipple
sparing mastectomies
4.  Conclusion
This case underscores the rare but real possibility of detect-
ing breast cancer incidentally following gynaecomastia surgery.
The treatment of DCIS in male patients requires an individualized
approach within the context of a multidisciplinary team taking into
consideration, the type, grade, site and size of the DCIS. While offer-
ing NSM, in treatment of DCIS the patient must be counselled about
limited follow-up data on recurrence and outcome.Conﬂict of interest statement
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